Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday. Here are some other stocks moving in today’s mid-day session. GainersIntelligent Bio Solutions Inc. (NASDAQ: INBS) gained 73% to $0.4853. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares surg…

Read More